Joe AK - Search Results

1

17HSD 2 may be higher in African-American breast cancer and is associated with estrogen receptor-negative tumors.

Yaeger R, Nolan PC, Su T, Avila-Bront A, Wang X, Cheung YK, Liu H, Rangarajan VS, Hibshoosh H, Powell CA, Joe AK. Yaeger R, et al. Among authors: joe ak. Cancer Genomics Proteomics. 2007 Sep-Oct;4(5):341-8. Cancer Genomics Proteomics. 2007. PMID: 17993718 Free article.

2

Cyclin D1 overexpression is associated with estrogen receptor expression in Caucasian but not African-American breast cancer.

Joe AK, Memeo L, Mckoy J, Mansukhani M, Liu H, Avila-Bront A, Romero J, Li H, Troxel A, Hibshoosh H. Joe AK, et al. Anticancer Res. 2005 Jan-Feb;25(1A):273-81. Anticancer Res. 2005. PMID: 15816548 Free article.

3

African-American/White differences in breast carcinoma.

Joe AK, Hibshoosh H. Joe AK, et al. Cancer. 2005 Aug 1;104(3):661-2; author reply 662-3. doi: 10.1002/cncr.21210. Cancer. 2005. PMID: 15918173 Free article. No abstract available.

4

Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa.

Yaeger R, Avila-Bront A, Abdul K, Nolan PC, Grann VR, Birchette MG, Choudhry S, Burchard EG, Beckman KB, Gorroochurn P, Ziv E, Consedine NS, Joe AK. Yaeger R, et al. Among authors: joe ak. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1329-38. doi: 10.1158/1055-9965.EPI-07-2505. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559547 Free PMC article.

5

Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer.

Joe AK, Arber N, Bose S, Heitjan D, Zhang Y, Weinstein IB, Hibshoosh H. Joe AK, et al. Anticancer Res. 2001 Sep-Oct;21(5):3535-9. Anticancer Res. 2001. PMID: 11848520

6

Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.

Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB. Joe AK, et al. Clin Cancer Res. 2002 Mar;8(3):893-903. Clin Cancer Res. 2002. PMID: 11895924

7

Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.

Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hibshoosh H, Cheung K, Friedman RA, Yang CS, Milne GL, Liu DD, Lee JJ, Abdul K, Bigg M, Foreman J, Su T, Wang X, Ahmed A, Neugut AI, Akpa E, Lippman SM, Perloff M, Brown PH, Lightdale CJ. Joe AK, et al. Cancer Prev Res (Phila). 2015 Dec;8(12):1131-7. doi: 10.1158/1940-6207.CAPR-14-0274-T. Epub 2015 Oct 15. Cancer Prev Res (Phila). 2015. PMID: 26471236 Free PMC article. Clinical Trial.

8

Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells.

Joe AK, Liu H, Xiao D, Soh JW, Pinto JT, Beer DG, Piazza GA, Thompson WJ, Weinstein IB. Joe AK, et al. J Exp Ther Oncol. 2003 Mar-Apr;3(2):83-94. doi: 10.1046/j.1359-4117.2003.01076.x. J Exp Ther Oncol. 2003. PMID: 12822514 Free article.

9

Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.

Lim JT, Joe AK, Suzui M, Shimizu M, Masuda M, Weinstein IB. Lim JT, et al. Among authors: joe ak. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3478-84. doi: 10.1158/1078-0432.CCR-05-2051. Clin Cancer Res. 2006. PMID: 16740773

10

Inhibition of BCL2 expression and activity increases H460 sensitivity to the growth inhibitory effects of polyphenon E.

Borgovan T, Bellistri JP, Slack KN, Kopelovich L, Desai M, Joe AK. Borgovan T, et al. Among authors: joe ak. J Exp Ther Oncol. 2009;8(2):129-44. J Exp Ther Oncol. 2009. PMID: 20192119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters